Viewport 01 · Category Topology
How the U.S. OTC cold and flu category is shaped
Two axes describe brand position. What each brand claims, and how it claims it. AXIV sits in the most-crowded cell of the map with the four highest-trust incumbents and the rhetorical posture of a private label.
circle size scaled to SBPI composite
What the map shows
Two halves that share consumers and not language
The category splits into mainstream symptom-relief OTC on one side and natural-immune on the other. Vicks, Mucinex, Tylenol Cold and Flu, Robitussin, Delsym, Zicam, and Theraflu talk about active ingredients, severity tiers, day-night occasion, and pharmacist trust. Sambucol, Airborne, Emergen-C, Oscillococcinum, Zarbee's, Genexa, Olly, Goli, Vitafusion, and Wellness Formula talk about elderberry, vitamin C, zinc, daily ritual, and first signs. The two halves share consumers. They do not share language. The hand-off moment between "I'm taking my daily immune gummy" and "I'm congested, I need Mucinex" has no brand attached to it.
Inside each half, the anchors are settled. Vicks owns Day-vs-Night as a brand-as-category mental model. Mucinex owns mucus and 12-hour duration. Tylenol carries the heritage analgesic across. Zicam is the only mainstream brand claiming duration-modification at the first sign. Theraflu has taken first-mover position on phenylephrine-free post the 2024 FDA proposed order. On the natural side, Sambucol owns the Original Black Elderberry founder claim. Oscillococcinum owns the homeopathic first-signs slot. Emergen-C owns vitamin C daily ritual. Zarbee's owns drug-free pediatric. Genexa has built Clean Medicine as the clearest category-position challenge to mainstream OTC. Each anchor sits in its own cell. The anchors do not collide.
What the topology says about AXIV is structural. AXIV currently lives in the most-crowded cell of the map. Symptom relief delivered through a compare-to value-challenger posture. It shares the symptom-relief row with the four highest-trust incumbents and shares the compare-to claim language with every store-brand private label. The white-space cells, where consumers are asking questions no brand answers, all sit somewhere else.
"Buy generic pills of each of those for a lot cheaper than NyQuil or ZzzQuil."
Reddit consumer discourse, identity-and-value driver. The shopper does not name AXIV. Source: research/consumer-language/06-emotional-drivers.md
Methodology appendix
Two axes describe brand position in this category. Axis 1 is the dominant narrative the brand pushes (what it claims). Axis 2 is the positioning posture (how it sells the claim). Brand placements grounded in observable claim language at the source URLs cited in research/competitors/mainstream/ and research/competitors/natural-immune/. AXIV placement reflects axiv.live as of 2026-05-18.
Axis 1 narratives: Symptom relief · Mucus action · Antiviral · Immune defense · Immune support · Sleep and recovery · Clean ingredients · Compare-to value.
Axis 2 postures: Clinical authority · Heritage trust · Natural credibility · Value challenger · Disruptor.
Circle size scaled to SBPI composite (square-root scaling). Source data: state/us-otc-cold-flu.json. Topology source: deliverables/03-category-topology.md.